Compare Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) vs Indonesia Energy Corporation Limited (INDO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio-Rad Laboratories, Inc. Class A Common Stock vs Indonesia Energy Corporation Limited — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $356.44 (market cap $9.43B), while Indonesia Energy Corporation Limited trades at $2.92 (market cap $45.55M). The key difference: Bio-Rad Laboratories, Inc. Class A Common Stock is far larger — about 207× Indonesia Energy Corporation Limited's market cap, and Bio-Rad Laboratories, Inc. Class A Common Stock is trading nearer its 52-week high, Indonesia Energy Corporation Limited nearer its low. Which is the better fit depends on your goals.
| BIO | INDO | |
|---|---|---|
Market Cap | $9.43B | $45.55M |
Sector | Health | Energy |
52-Week High | $356.25 | $6.74 |
52-Week Low | $241.71 | $2.49 |
Enterprise Value | $9.18B | $40.92M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio-Rad Laboratories (BIO) trades at $362.08, up 2.13% daily, near its 52-week high. The stock shows a bullish technical trend with strong moving averages, though RSI indicates overbought conditions. Fundamentally, Q2 2026 earnings beat estimates with EPS of $2.62 versus $1.75 expected, and revenue remains stable around $2.6 billion. Net income turned positive in 2025 after prior losses, with a current net margin of 29.41%. Analyst consensus is Buy with a $350 price target, and institutional holdings increased, as noted by Amundi's 1,763.4% stake growth per SEC filing on August 5, 2026.
Outlook is cautiously optimistic with solid earnings recovery and institutional support, but risks include high P/E of 43.39, potential overvaluation, and reliance on academic research markets. Investors should weigh strong profitability against valuation concerns and monitor upcoming Q3 earnings for sustained growth.
Indonesia Energy Corporation (INDO) trades at $2.93, up 0.34% with a bullish technical signal. The stock shows negative profitability metrics including -253.4% net income margin and -26.95% ROE, though recent drilling operations at the Kruh Block indicate operational progress. Analyst consensus is unanimously bullish with 3 buy ratings. Technical indicators show bullish moving averages and neutral oscillators with RSI at 60.28.
While current fundamentals show significant losses, the company's active drilling program and 100% analyst buy rating suggest potential upside if operational execution improves. Key risks include execution challenges in oil exploration and sustained negative cash flow. The stock presents speculative potential for investors comfortable with high-risk energy exploration plays.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bio-Rad Laboratories, Inc. Class A Common Stock
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →About Indonesia Energy Corporation Limited
Indonesia Energy is an oil and gas exploration and production company. It focuses on identifying and developing energy resources in Indonesia, primarily through its Kruh and Citarum blocks.
Read more on INDO →
